Anteris Technologies

Summary

History

Mission

Vision

References

Summary

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

History

Anteris Technologies was founded in 2016 by healthcare innovator Dr. Mark Stenz. Since then, the company has grown from a small team of three to a team of over 100. Anteris has released a number of proprietary solutions for healthcare providers, including a mobile app for patient records, a cloud-based billing system, and a web-based platform for communication between providers and their patients.

Mission

At Anteris Technologies, our mission is to improve patient access and engagement in healthcare services by developing innovative technologies that streamline processes and facilitate communication between patients and providers.

Vision

Our vision is to be the leader in healthcare technology solutions, empowering providers to deliver high-quality care, and providing patients with the tools they need to participate actively in their health and well-being.

References

https://in.investing.com/equities/admedus-fpo

https://finance.yahoo.com/quote/AVR.AX/profile?p=AVR.AX

https://www.crunchbase.com/organization/allied-healthcare-group

https://www.anteristech.com

Leadership team

Mr. Wayne G. Paterson (CEO, MD & Exec. Director)

Mr. Matthew McDonnell (Chief Financial Officer)

Mr. David St. Denis (Chief Operating Officer)

Products / Services

Biotechnology, Health Care, Medical

Number of Employees